Related Experiment Videos
[Chloroquine-induced isolated palatal hyperpigmentation]
1Bereichs Medizin der Friedrich-Schiller-Universität Jena.
Deutsche Zeitschrift Fur Mund-, Kiefer- Und Gesichts-Chirurgie
|March 1, 1990
Summary
Chloroquine therapy for cutaneous lupus erythematosus can cause harmless slate-greyish palatinum discoloration due to increased melanin. Consult an oculist to rule out retinopathia.
Area of Science:
- Dermatology
- Pharmacology
Background:
- Cutaneous lupus erythematosus (CLE) is a chronic autoimmune condition.
- Chloroquine is a medication used to treat various conditions, including CLE.
- Adverse drug reactions require careful monitoring during treatment.
Observation:
- A 28-year-old woman undergoing chloroquine therapy for CLE developed an isolated slate-greyish discoloration of her palatinum.
Findings:
- The observed palatinum hyperpigmentation is a benign side effect.
- This discoloration results from increased melanin synthesis, not drug deposition.
- Ophthalmological examination is recommended to exclude potential chloroquine-induced retinopathia.
Implications:
- This finding highlights a rare, harmless side effect of chloroquine in CLE treatment.
- Awareness of this pigmentation can prevent misdiagnosis.
- Emphasizes the importance of comprehensive patient monitoring, including ocular health, during chloroquine therapy.